TLR3 and neoplasm: Activation of TLR3/7/8 induces alveolar macrophages to an CD86highCD206lowArg1low M1-like antitumor phenotype, enhancing the expression of T-cell chemokines CXCL10 and CCL5 and effectively suppressing tumor metastasis (79).